参考文献/References:
［1］金凡力,张晓然.去白细胞悬浮红细胞输血技术在急救输血中的实践及进展研究［J］.中外医疗,2024,43(15):185-189.［2］VAMVAKAS EC.The abandoned controversy surrounding universal white blood cell reduction［J］.Blood Transfus,2014,12(2):143-145.［3］SEFTEL MD,GROWE GH,PETR-ASZKO T,et al.Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness［J］.Blood,2004,103(1):333-339.［4］KING KE,SHIREY RS,THOMAN SK,et al.Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs［J］. Transfusion,2004,44(1):25-29. ［5］HALL S,DANBY R,OSMAN H,et al.Transfu sion in CMV seronegative T-depleted allogeneic stem cell transplant recipients with CMV-unselected blood components results in zero CMV transmissions in the era of universal leukocyte reduction:a UK dual center experience［J］.Transfus Med,2015,25(6):418-423. ［6］VAMVAKAS EC.Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion？A review of the literature and meta-analysis［J］.Transfus Med Rev,2005,19(3):181-199.［7］QU L,XU S,ROWE D,et al.Efficacy of epstein-rarr virus removal by leukoreduction of red blood cells［J］.Transfusion,2005,45(4):591-595.?倓［8］MALONGA GA,DIENTA S,TRAORE FT,et al.Human herpesvirus 8 seroprevalence among blood donors in Mali［J］.J Med Virol,2022,94(9):4554-4558. ［9］CSAIRE R,KROB-BAUCHET B,BOURDONN O,et al.Evaluation of HTLV-I removal by filtration of blood cell components in a routine setting［J］. Transfusion,2004,44(1):42-48. ［10］CERVIA JS,SOWEMIMO-COKER SO,ORTOLANO GA,et al.An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant creutzfeldt-jakob disease［J］.Transfus Med Rev,2006,20(3):190-206. ［11］BUSCH MP,LEE TH,HEITMAN J.Allogenic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent HIV-I-Infection［J］. Blood,1992,80(8):2128-2135. ［12］GUPTA S,PANDEY-RAI S,SRIVASTAVA S,et al.Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to cellular blood components:a 5 year study［J］.International Blood Research & Reviews, 2014,2(6):279-288. ［13］CHIPOLLINI JJ,TANG DH,PATEL SY,et al.Perioperative transfusion of leukocyte-depleted blood products in contemporary radical cystectomy cohort does not adversely impact short-term survival［J］.Urology,2017,103:142-148. ［14］王云英,李兴禄,张莉萍,等.血液经白细胞过滤后红细胞膜的损伤［J］.重庆医科大学学报,2008,33(2):210-215． ［15］WORTHAM ST,ORTOLANO GA,WENZ B. A brief history of blood filtration:clot screens,microaggregate removal,and leukocyte reduction［J］. Transfus Med Rev,2003, 17(3):216-222. ［16］URIAS EVR,TELES LF,LULA JF,et al.Leukocyte filters:a review of the mechanisms and applications in hemotherapy［J］.Rev Assoc Med Bras,2021,67(7):1056-1060. ［17］韩 玮.去白细胞成分输血合理应用策略的实验研究［D］.北京:中国人民解放军军事医学科学院,2008.［18］SHARMA RR,MARWAHA N.Leukoreduced blood components:advantages and strategies for its implementation in developing countries［J］.Asian J Transfus Sci,2010,4(1):3-8. ［19］许丽影.去白细胞输血预防非溶血性发热性输血反应的临床应用分析［J］.中西医结合心血管病电子杂志,2020,8(33):44,198.［20］周 燕,温丽娜,周冰，等.输注去白细胞悬浮红细胞预防非溶血性发热输血反应的Meta分析［J］.贵州中医药大学学报,2020,42(2):61-63，78.［21］HARVEY AR,BASAVARAJU SV,CHUNG KW,et al.Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module,United States,2010 to 2012［J］.Transfusion,2015,55(4):709-718. ［22］WANG H,REN D,SUN H,et al.Research progress on febrile non-hemolytic-transfusion reaction:a narrative review［J］.Ann Transl Med,2022,10(24):1401.［23］DADASHI M,OSTADALI M,MOHAMMADI S,et al.Major Histocompatibility Complex(MHC) antigens polymorphism and alloimmunization study in thalassemia patients with febrile non-hemolytic transfusion reaction (FNHTR)［J］.Transfus Clin Biol,2023,30(2):205-211. ［24］YANAGISAWA R,YAMANAKA R,SHIMODAIRA S.Analysis of clinical factors associated with the occurrence time of allergic transfusion reactions or febrile non-hemolytic transfusion reactions［J］.Ann Clin Lab Sci,2022,52(3):382-390.［25］LARSEN R,SANDHU N,HEEGAARD NHH,et al.Changes in circulating inflammatory markers following febrile non-haemolytic transfusion reactions to leucoreduced red cells［J］.Vox Sang,2018,113(1):76-79. ［26］TSANTES AE,KYRIAKOU E,NIKOLOPOULOS GK,et al.Cost-effectiveness of leucoreduction for prevention of febrile non-haemolytic transfusion reactions［J］.Blood Transfus,2014,12(2):232-237. ［27］ADANE T,ENAWGAW B.Human leukocyte antigen alloimmunization prevention mechanisms in blood transfusion［J］.Asian J Transfus Sci,2023,17(2):264-272. ［28］许 珣,管 政,汤博悦.血小板型去LDF的临床应用［J］.中华全科医学,2015,13(10):1684-1686.［29］HATAKEYAMA N,HORI T,YAMAMOTO M,et al.Platelet transfusion refractoriness attributable to HLA antibodies produced by donor-derived cells after allogeneic bone marrow transplantation from one HLA-antigen-mismatched mother［J］.Pediatr Transplant,2011,15(8):177-182. ［30］李萍.去白细胞血液成分降低血小板输注无效发生率效果评价［J］.临床医药文献电子杂志,2019,6(7):34. ［31］ENRIGHT H,DAVIS K,GERNSHEIMER T,et al.Factors influencing moderate to severe reactions to PLT transfusions:experience of the TRAP multicenter clinical trial［J］.Transfusion, 2003,43(11):1545-1552.［32］DEJIGOV MONTEIRO DA SILVA N,NUKUI Y,TAKAHASHI J,et al.Effect of post-storage filters vs. pre-storage filters for leukoreduction of blood components on clinical outcomes:a systematic review and meta-analysis［J］.Syst Rev,2024,13(1):196.［33］王晶.X射线血液辐照技术及其临床应用［J］.中国医疗器械信息,2019,25(21):37-39，85.［34］叶立文.预防输血相关性移植物抗宿主病发生的研究进展［J］.标记免疫分析与临床,2015,22(12):1297-1299.［35］梁晓虎,李建民,沈 莉,等.血液去除白细胞概况［J］.河北医药,2005(1):43-44.［36］林洁,庄 远.辐照血液临床应用中国专家共识［J］.中国输血杂志,2023, 36(9):757-766.［37］SOLHEIM BG.Pathogen reduction of blood components［J］.Transfus Apher Sci,2008,39(1):75-82. ［38］韩海心,杨 讯,王波,等.辐照去白细胞悬浮红细胞治疗急性白血病的疗效观察及对患者免疫功能的影响［J］.实用癌症杂志,2025,40(2):341-344.［39］BOODRAM S,EVANS E.Use of leukocyte-depleting filters during cardiac surgery with cardiopulmonary bypass:a review［J］.J Extra Corpor Technol,2008,40(1):27-42. ［40］SIEVERT A.Leukocyte depletion as a mechanism for reducing neutrophil-mediated ischemic-reperfusion injury during transplantation［J］.J Extra Corpor Technol,2003,35(1):48-52. ［41］ZHANG X,ZHOU C,ZHUANG J,et al.Effects of leukocyte depletion on cardiopulmonary protection and inflammation after valve surgery［J］.Int J Artif Organs,2010,33(11):812-818. ［42］BAKHTIARY F,MORITZ A,KLEINE P,et al.Leukocyte depletion during cardiac surgery with extracorporeal circulation in high risk patients［J］.Inflamm Res,2008,57(12):577-585.［43］ROTH M,KRAUS B,SCHEFFOLD T,et al.The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction:a randomized,double-blind study［J］.J Thorac Cardiovasc Surg,2000,120(4):642-650. ［44］SMIT JJ,DE VRIES AJ,GU YJ,et al.Efficiency and safety of leukocyte filtration during cardiopulmonary bypass for cardiac surgery［J］.Transfus Sci,1999,20(3):151-165. ［45］WARREN O,ALEXIOU C,MASSEY R,et al.The effects of various leukocyte filtration strategies in cardiac surgery［J］.Eur J Cardiothorac Surg,2007,31(4):665-676. ［46］卢少芬,杜明仪,谭晓颖,等.全血过滤白细胞时间长短对血液质量的影响研究［J］.中国医药科学,2021,11(23):186-189.［47］李志坚,刘 伟,白 雪.血液成分滤除白细胞的影响因素及关键控制点［J］.实用医技杂志,2018,25(3):288-289.［48］WANG H,REN D,SUN H,et al.Research progress on febrile non-hemolytic transfusion reaction:a narrative review［J］.Ann Transl Med,2022,10(24):1401.［49］SHIN GS,KIM B,KIM SH,et al.Comparison of efficiency between pre-storage and post-storage filtration by leukoreduction blood filter［J］.Biomedical Science Letters,2017, 23(2):111-117.